Clinical Trials
6 trialsNCT00003337 2021-08-16
Radiolabeled Monoclonal Antibody in the Detection and Staging of Patients With Non-Hodgkin's Lymphoma
Gilead Sciences
Phase 3 Unknown
NCT00003338 2021-08-16
Monoclonal Antibodies in Detecting Residual Disease in Patients Who Have Been Treated for Non-Hodgkin's Lymphoma
Gilead Sciences
Phase 2/3 Unknown
NCT00054834 2021-08-16
Study of 90Y-hLL2 to Treat Non-Hodgkin's Lymphoma
Gilead Sciences
Phase 1 Terminated
NCT00421395 2021-08-16
Safety Study of NHL With 90Y-hLL2 IgG
Gilead Sciences
Phase 1/2 Completed
NCT00398372 2011-06-02
Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma Patients Receiving Antibody Treatment
Stanford University
Phase NA Completed
NCT00044902 2007-12-28
Monoclonal Antibody Treatment for Non-Hodgkin's Lymphoma (Low-Grade)
Amgen
Phase 2 Completed